The following have been confirmed as Keynote Speakers.
Theodore Alexandrov
European Molecular Biology Laboratory (EMBL)
Theodore Alexandrov is a team leader at the European Molecular Biology Laboratory (EMBL), the Europe’s leading life science laboratory. He is also the head of the EMBL Metabolomics Core Facility and an Assistant Adjunct Professor at the Skaggs School of Pharmacy, University of California San Diego, USA. The Alexandrov team at EMBL aims to reveal the secrets of metabolism in time and space in tissues and single cells by developing experimental and computational methods. The team unites interdisciplinary scientists from biology, chemistry, and computer science as well as software engineers and data analysts. The developed computational methods are integrated into various open-source and industrial software packages. Since 2014, the team develops and provides for free the cloud software METASPACE for metabolite ID in imaging mass spectrometry, used by universities, governmental organizations, and pharma companies. Theodore Alexandrov is a grantee of an ERC Consolidator project focused on studying metabolism in single cells, as well as of various other European, national, NIH, and industrially-funded projects. He has co-founded and scientifically directed the company SCiLS and has over 80 journal publications and 6 patents in the field of spatial and single-cell -omics.
Koel Chaudhury
School of Medical Science & Technology (SMST),
Indian Institute of Technology Kharagpur - India
Rachel Kelly
Brigham and Women's Hospital, Harvard Medical School
Du Toit Loots
North-West University (NWU) - South Africa
Prof Du Toit Loots, Research Director of “Human Metabolomics” and Sub-programme Head of the “Infectious and Acquired Disease Metabolomics Unit” at the North-West University (NWU) - South Africa, has spent the majority of his research career developing and using metabolomics technology for new biomarker discovery, in order to better characterize, diagnose and treat diseases of high global prevalence, such as TB and HIV. Prof Loots has to date contributed to over 150 publications, 83 conference proceedings, and trained over 80 PhD, MSc and BSc Hons students in metabolomics. Prof Loots has additionally registered 2 full patents with application to TB diagnostics, and published a new synthesis method for NaFe(III)EDTA, a highly bioavailable form of iron for combating anaemia globally. In recognition of these efforts, he received amongst others the: International Nestle Nutrition Institute for Africa Research Award; Janssen-Cilag Award, International ARP Walker Research Award, International Scripps Centre for Integrative Medicine's Research Award, and most downloaded paper: Awarded by Wiley and Sons Inc. in 2020.
Peter J. Meikle
Baker Heart and Diabetes Institute
Professor Peter Meikle is the Head of the Systems Biology Domain, Co-Lead of the Obesity and Lipids Program and is Head of the Metabolomics Laboratory at the Baker Heart and Diabetes Institute. He is Editor in Chief of Metabolites, the official Journal of the International Metabolomics Society. His research has a focus on the dysregulation of lipid metabolism associated with metabolic diseases including obesity, diabetes, cardiovascular and Alzheimer’s disease and its relationship to the pathogenesis of these disease states. This work is leading to new approaches to early diagnosis and risk assessment, and to the development of new lipid modulating therapies for chronic disease.
Carina Mels
Hypertension in Africa Research Team
Carina Mels is full-time Research Professor and Director of the Hypertension in Africa Research Team (HART) at the North-West University (NWU), South Africa. The vision of HART is to be nationally and internationally recognised for excellence in cardiovascular research. The team is involved in various population-based studies, including epidemiological and clinical research which focus on the early development and progression of hypertension-mediated organ damage and its comorbidities. HART is a premier centre on hypertension research as acknowledged by their NWU status as Centre of Excellence. They also host the prestigious Medical Research Council Extra Mural Unit for Hypertension and Cardiovascular Disease.
Carina has published more than 70 peer-reviewed papers and acted as post-graduate study supervisor to more than 20 Masters and Ph.D students. She is the local Principal Investigator of the African PRospective study on the Early Detection and Identification of Cardiovascular disease and HyperTension (African-PREDICT). Carina is actively involved in the mentorship programme of the National Research Foundation aimed at capacity building for young graduates or post-graduates. She serves on the Board of Directors and the Next Generation Committee of the Southern African Hypertension Society (SAHS). As a Professional member of the International Society of Hypertension (ISH) she is also involved in the African Regional Advisory Group with the aim to alleviate the burden of hypertension on the African continent.
With her background in biochemistry and metabolism she took the opportunity to use proteomics and metabolomics to investigate early changes associated with the development of future cardiovascular disease. In the next 10 to 20 years she aspires to apply her skills and knowledge gained through her research funded by various national bodies to identify novel biomarkers indicative of the early development of cardiovascular disease. This can ultimately aid to prevent hypertension and associated cardiovascular conditions through implementation of early, pre-clinical detection techniques to guide individualised medicine.
Farhana Pinu
New Zealand Institute for Plant and Food Research Ltd
Farhana is a Senior Scientist and Programme Leader of the New Zealand Institute for Plant and Food Research Ltd (PFR). She completed a PhD on microbial metabolomics from The University of Auckland (UoA), New Zealand in 2012 and started working in PFR soon after. Farhana has contributed to some of the pioneering work on the application of targeted and untargeted metabolomics in grape and wine research. Her current projects focus on the development and optimisation of metabolomics, lipdomics, flavoromics and imaging approaches using mass spectrometry, particularly to study fermentation outcomes, grape and yeast metabolism. Farhana is also investigating the impact of biodivery and ecosystem services in horticultural systems as part of a fundamental research programme in New Zealand.
Farhana is the current President of Australia and New Zealand Metabolomics Society. She is also one of the key organizers of ANZ metabolomics conference (ANZMET) and Asia and Oceania Metabolomics Forum. Farhana is an editorial board member of Food Research International and a guest editor of special issues of MDPI journal Metabolites.
.
Emma Schymanski
Luxembourg Centre for Systems Biomedicine (LCSB)
Associate Professor Emma Schymanski is head of the Environmental Cheminformatics (ECI) group at the Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg. In 2018 she received a Luxembourg National Research Fund (FNR) ATTRACT Fellowship to establish her group in Luxembourg, following a 6-year postdoc at Eawag, the Swiss Federal Institute of Aquatic Science and Technology and a PhD at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany. Before undertaking her PhD, she worked as a consulting environmental engineer in Perth, Australia. She has over 80 publications and a book, and is involved in many collaborative software efforts. Her research combines cheminformatics and computational (high resolution) mass spectrometry approaches to elucidate the unknowns in complex samples, primarily with non-target screening, and relating these to environmental causes of disease. An advocate for open science, she is involved in and organizes several European and worldwide activities to improve the exchange of data, information and ideas between scientists to push progress in this field, including NORMAN Network activities (e.g. NORMAN-SLE https://www.norman-network.com/nds/SLE/), MassBank (https://massbank.eu/MassBank/), MetFrag (https://msbi.ipb-halle.de/MetFrag/) and PubChemLite for Exposomics (https://doi.org/10.5281/zenodo.4432123).
Alessandra Sussulini
University of Campinas (Unicamp)
Prof. Dr. Alessandra Sussulini received her Ph.D. in Analytical Chemistry from the University of Campinas (Unicamp), Brazil, where she is currently an Assistant Professor. Her research activities are focused on the application of mass spectrometry-based multi-omics strategies to identify biomarkers that allow unravelling the molecular bases of diseases (especially psychiatric and neurodegenerative), as well as the mechanisms of action of different drug therapies.
Marina F.M. Tavares
Center for Multiplatform Metabolomics Studies at IQ-USP
Marina F.M. Tavares was born October 10, 1959 in Sao Paulo, SP, Brazil. She received a B.S. degree in Chemistry from University of Sao Paulo, Sao Paulo, SP, Brazil in 1980, a M.Sc. in Analytical Chemistry from University of Sao Paulo (with Prof. Roberto Tokoro) in 1986 and a Ph.D. in Analytical Chemistry from Michigan State University, East Lansing, MI, U.S.A. in 1993 (with Prof. Victoria L. McGuffin). She joined the Institute of Chemistry of University of Sao Paulo (IQ-USP) in 1997 as an assistant professor, became associate professor in 2003 and full professor in 2008. In 2010, she spent her sabbatical year training in metabolomics at the Faculty of Medicine, Imperial College London (with Jeremy K. Nicholson/Elaine Holmes/Jasmina Saric). In 2020, she founded the Center for Multiplatform Metabolomics Studies (CEMM, in Portuguese) at IQ-USP. To date she published 9 book chapters, 120 articles and participated in more than 200 symposia and conferences, delivering 50 lectures and 15 short courses; 24 doctorate and 18 master students graduated under her guidance.
The group has hosted in Brazil the 4th, the 11th, the 16th, and the 20th Latin American Symposium on Biotechnology, Biomedical, Biopharmaceutical and Industrial Applications of Capillary Electrophoresis and Microchip Technology (LACE), and the 34th International Symposium on Microscale Separations and Bioanalysis (MSB 2018).
Present research interests include: separation science, physical chemistry and clinical metabolomics. Projects are focused on modeling, simulation, method development and optimization of conditions for the separation and analysis of molecules of clinical, forensic, nutritional, pharmaceutical, cosmetological, environmental and industrial importance using modern separation techniques, and more recently, in clinical/forensic metabolomics involving gestational exposure to drugs of abuse and atmosphere pollution, indoors exposition, cardiovascular diseases, acute myocardial infarction, impact of weight-reducing gastroplasty on diabetes mellitus, urinary tract diseases, kidney injury and transplant, salivary glands, lung, breast, and prostate cancer, benign prostatic enlargement, and neglected diseases.
Yulan Wang
Singapore Phenome Center, Lee Kong Chian School of Medicine
Professor Wang graduated in Chemical Engineering at Shaanxi University of Science and Technology, P.R. China in 1986 and got her PhD in Physical Chemistry in 1997 from University of East Anglia, UK. Professor Wang joined Institute of Food Research and John Inners Center, UK, during 1998-2001 for her postdoctoral research where she applied her NMR skills in food sciences.
From 2001 to 2007, she worked at Imperial College London in the field of metabonomics as research fellow. She combined NMR and LC-MS spectroscopic techniques with computational modeling techniques to investigate metabolic effects of infectious diseases, nutritional interventions.
In 2007, she was awarded “100 talent program” by the Chinese Academy of Science and became professor at Wuhan Institute of Physics and Mathematics. 08/2018, she joined LKCMedicine, Nanyang Technological University, and become director of Singapore Phenome Center.
Prof. Wang focused her research in development of metabonomics techniques, including NMR and MS-based techniques. She has applied the metabolomics technique to a number of disease areas, including infectious diseases, cancer, neurodegenerative disease and gastrointestinal tract disease, as well as drug toxicity. She had been an executive committee member of “experimental nuclear magnetic resonance conference”. She is also an editorial board member of several journals, including, scientific reports, metabolomics, current metabolomics.
Bing Yu
University of Texas Health Science Center at Houston
Dr. Yu is a molecular epidemiologist and her research focuses on discovering novel biomarkers and underlying biological pathways of cardiopulmonary disease using cutting-edge omics technologies, including whole genome sequencing, proteomics and metabolomics. Dr. Yu has been leading multiple omics projects in large consortia including the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, the Trans-Omics for Precision Medicine (TOPMed) Program and the COnsortium of METabolomics Studies (COMETS). Her work on integrating omics for cardiovascular disease has been sponsored by National Institute of Health and American Heart Association.
METABOLOMICS SOCIETY | metabolomicssociety.org